吴哲, 王东, 陈晓梅, 明智, 刘可, 晏军. 3种全脑放疗技术对中耳剂量学研究[J]. 中国辐射卫生, 2021, 30(3): 276-281.
WU Zhe, WANG Dong, CHEN Xiaomei, MING Zhi, LIU Ke, YAN Jun. Dosimetric study on middle ear with three whole-brain radiotherapy techniques. , 2021, 30(3): 276-281.
[1] Korkmaz Kirakli E, Oztekin O. Is hippocampal avoidance during whole-brain radiotherapy risky for patients with small-cell lung cancer?hippocampal metastasis rate and associated risk factors[J]. Technol Cancer Res Treat, 2017, 16(6): 1202-1208. DOI: 10.1177/1533034617742301 [2] 孟曼, 毕金玲, 黄勇. 脑转移瘤全脑放疗疗效与预后相关因素分析[J]. 中国辐射卫生,2019,28(4):458-461, 472. DOI: 10.13491/j.issn.1004-714x.2019.04.030 Meng M, Bi JL, Huang Y. Analysis of factors related to the efficacy and prognosis of brain metastases in whole brain radiotherapy[J]. Chin J Radiol Health, 2019, 28(4): 458-461, 472. DOI: 10.13491/j.issn.1004-714x.2019.04.030 [3] 宋俊韬, 李学源, 聂东. 两种适形放疗技术在肺癌脑转移瘤中的疗效对比[J]. 中国辐射卫生,2016,25(1):104-106. DOI: 10.13491/j.cnki.issn.1004-714x.2016.01.042 Song JT, Li XY, Nie D. Comparative analysis of two methods for 3D-CRT with brain metastases of non-small cell lung cancer[J]. Chin J Radiol Health, 2016, 25(1): 104-106. DOI: 10.13491/j.cnki.issn.1004-714x.2016.01.042 [4] 陈杰, 朱云云, 陈明东, 等. 全脑照射调强放疗和常规放疗剂量学对比[J]. 医疗卫生装备,2016,37(2):109-111. DOI: 10.7687/J.ISSN1003-8868.2016.02.109 Chen J, Zhu YY, Chen MD, et al. Dosimetric comparision of cranial irradiation between intensity-modulated radiotherapy and conventional radiotherapy[J]. Chin Med Equip J, 2016, 37(2): 109-111. DOI: 10.7687/J.ISSN1003-8868.2016.02.109 [5] Upadhya I, Jariwala N, Datar J. Ototoxic effects of irradiation[J]. Indian J Otolaryngol Head Neck Surg, 2011, 63(2): 151-154. DOI: 10.1007/s12070-011-0142-9 [6] 杨建明. 鼻咽癌放疗前后腭帆张肌横截面积的改变与放射性中耳炎的相关性[J]. 山东大学耳鼻喉眼学报,2014,28(1):31-33. DOI: 10.6040/j.issn.1673-3770.0.2013.212 Yang JM. Relationship between radioactive otitis media and changes in cross section area of tensor veli palatine(TVP)muscle after radiotherapy in patients with nasopharyngeal carcinoma[J]. J Otolaryngol Ophthalmol Shandong Univ, 2014, 28(1): 31-33. DOI: 10.6040/j.issn.1673-3770.0.2013.212 [7] Hsin CH, Tseng HC, Lin HP, et al. Post-irradiation otitis media, rhinosinusitis, and their interrelationship in nasopharyngeal carcinoma patients treated by IMRT[J]. Eur Arch Otorhinolaryngol, 2016, 273(2): 471-477. DOI: 10.1007/s00405-015-3518-8 [8] Stoker J, Vora S, Patel A, et al. Advantages of intensity modulated proton therapy during hippocampal avoidance whole brain radiation therapy[J]. Phys Imaging Radiat Oncol, 2018, 8: 28-32. DOI: 10.1016/j.phro.2018.11.001 [9] 单书灿, 欧丹, 韩一旻, 等. 全脑放射治疗海马区保护的剂量学研究[J]. 中国医学物理学杂志,2019,36(5):546-550. DOI: 10.3969/j.issn.1005-202X.2019.05.010 Shan SC, Ou D, Han YM, et al. Dosimetric research on hippocampal-sparing whole brain radiotherapy[J]. Chin J Med Phys, 2019, 36(5): 546-550. DOI: 10.3969/j.issn.1005-202X.2019.05.010 [10] 叶峰. 鼻咽癌调强放疗放射毒性与临床及放射剂量学因素的相关性分析[D]. 广州: 南方医科大学, 2012. Ye F. Analyses of clinical and dosimetric parameters associated with radiation-induced toxicities in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy[D]. Guangzhou: Southern Medical University, 2012. [11] Wang SZ, Wang WF, Zhang HY, et al. Analysis of anatomical factors controlling the morbidity of radiation-induced otitis media with effusion[J]. Radiother Oncol, 2007, 85(3): 463-468. DOI: 10.1016/j.radonc.2007.10.007 [12] Wang SZ, Li J, Miyamoto CT, et al. A study of middle ear function in the treatment of nasopharyngeal carcinoma with IMRT technique[J]. Radiother Oncol, 2009, 93(3): 530-533. DOI: 10.1016/j.radonc.2009.09.013 [13] 林浩然, 李郁明, 杨田福, 等. 鼻咽癌放疗并发分泌性中耳炎的临床病理特征及影响因素分析[J]. 临床医学工程,2020,27(7):875-876. DOI: 10.3969/j.issn.1674-4659.2020.07.0875 Lin HR, Li YM, Yang TF, et al. Analysis on the clinicopathological characteristics and influencing factors of nasopharyngeal carcinoma radiotherapy complicated with secretory otitis media[J]. Clin Med Eng, 2020, 27(7): 875-876. DOI: 10.3969/j.issn.1674-4659.2020.07.0875 [14] Akazawa K,Doi H, Ohta S, et al. Relationship between Eustachian tube dysfunction and otitis media with effusion in radiotherapy patients[J]. J Laryngol Otol, 2018, 132(2): 111-116. DOI: 10.1017/S0022215118000014 [15] Pan CC, Eisbruch A, Lee JS, et al. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients[J]. Int J Radiat Oncol Biol Phys, 2005, 61(5): 1393-1402. DOI: 10.1016/j.ijrobp.2004.08.019 [16] Chan SH, Ng WT, Kam KL, et al. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis[J]. Int J Radiat Oncol, 2009, 73(5): 1335-1342. DOI: 10.1016/j.ijrobp.2008.07.034 [17] Jereczek-Fossa BA, Rondi E, Zarowski A, et al. Prospective study on the dose distribution to the acoustic structures during postoperative 3D conformal radiotherapy for parotid tumors: dosimetric and audiometric aspects[J]. Et Al, 2011, 187(6): 350-356. DOI: 10.1007/s00066-011-2170-5 [18] Hitchcock YJ, Tward JD, Szabo A, et al. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients[J]. Int J Radiat Oncol Biol Phys, 2009, 73(3): 779-788. DOI: 10.1016/j.ijrobp.2008.05.040
